BioCentury
ARTICLE | Clinical News

XP21279: Phase Ib data

October 4, 2010 7:00 AM UTC

A crossover, open-label Phase Ib trial in 10 PD patients with motor fluctuations showed that XP21279 plus carbidopa significantly reduced variability of L-dopa concentration as measured by mean absolu...